Martina Dameri

Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer

A. Ballestrero, G. Zoppoli, L. Del Mastro, 2022, JCO precision oncology.

Assessment of Circulating Nucleic Acids in Cancer: From Current Status to Future Perspectives and Potential Clinical Applications

A. Ballestrero, G. Zoppoli, G. Cirmena, 2021, Cancers.

Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study

A. Ballestrero, G. Zoppoli, A. De Maria, 2021, Journal of translational medicine.

ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC)

L. Magnani, A. Ballestrero, G. Pruneri, 2023, PLoS genetics.

The chromodomain helicase CHD4 regulates ERBB2 signaling pathway and autophagy in ERBB2+ breast cancer cells

K. Cortese, P. Castagnola, L. Lanfrancone, 2019, Biology Open.

Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer

A. Ballestrero, G. Pruneri, G. Zoppoli, 2021, International journal of molecular sciences.

Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: a critical review of the literature for the RENOVATE study protocol.

A. Ballestrero, G. Fanelli, G. Zoppoli, 2023, Critical reviews in oncology/hematology.

Imaging of Endocytic Trafficking and Extracellular Vesicles Released Under Neratinib Treatment in ERBB2+ Breast Cancer Cells

K. Cortese, P. Castagnola, M. Gagliani, 2021, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Development of a hoRizontal data intEgration classifier for NOn-invasive early diAgnosis of breasT cancEr: the RENOVATE study protocol

A. Ballestrero, G. Zoppoli, A. Tagliafico, 2021, BMJ Open.

Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib

A. Ballestrero, G. Zoppoli, A. Tagliafico, 2023, Tumori.